Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(40%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Other(1)

Detailed Status

Completed2

Active, not recruiting1

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

active_not_recruiting120%

completed240%

unknown120%

recruiting120%

Recent Activity

2 active trials

Showing 5 of 5

recruiting

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

NCT04661657

completednot_applicable

Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts

NCT02661529

Clinical Trials (5)

Showing 5 of 5 trials

NCT05379101

Intracardiac Flow Assessment in Cardiac Amyloidosis

Recruiting

NCT06420895

Health Data Warehouse on Aortic Insufficiency

Active Not Recruiting

NCT05592301

Patent Foramen Ovale (PFO) and Risk of Perioperative Stroke

Unknown

NCT04661657

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

Completed

NCT02661529Not Applicable

Enhancement of Contrast Opacification for Echocardiographic Imaging of the Right Heart and Shunts

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 5